Portfolios
Track your investments in one place, get AI insights, and more
Top movers in your lists
arrow_downward Symbols arrow_downward Symbols | arrow_downward Price | arrow_downward Change | arrow_downward % Change | Trend | arrow_downward Prev Close | arrow_downward Open | arrow_downward High | arrow_downward Low | arrow_downward Volume | arrow_downward Mkt Cap | |
|---|---|---|---|---|---|---|---|---|---|---|---|
SIXV Health care | SIXV +3.54% arrow_upward | 1,774.17 | +60.67 arrow_upward | +3.54% arrow_upward | — | 1,713.50 | 1,738.09 | 1,780.66 | 1,738.09 | — | — |
SIXB Materials | SIXB +2.00% arrow_upward | 1,120.33 | +21.99 arrow_upward | +2.00% arrow_upward | — | 1,098.55 | 1,102.59 | 1,123.50 | 1,102.59 | — | — |
SIXY Discretionary | SIXY +1.40% arrow_upward | 2,384.14 | +32.82 arrow_upward | +1.40% arrow_upward | — | 2,351.32 | 2,360.16 | 2,386.46 | 2,360.16 | — | — |
SIXR Staples | SIXR +1.34% arrow_upward | 874.87 | +11.54 arrow_upward | +1.34% arrow_upward | — | 863.33 | 865.66 | 879.41 | 865.35 | — | — |
SIXT Technology | SIXT -0.99% arrow_downward | 3,699.88 | -37.08 arrow_downward | -0.99% arrow_downward | — | 3,736.96 | 3,754.07 | 3,762.28 | 3,687.71 | — | — |
US market summary
Wall Street rebounds following sharp technology selloff
Major U.S. stock indexes opened higher as equity markets staged a recovery from a steep, technology-led downturn. The prior session saw significant losses across the S&P 500, Nasdaq, and Dow Jones Industrial Average due to fading momentum in artificial intelligence and semiconductor stocks.
search_spark
Dive deeper with AI
Treasury yields plunge as government scales up debt buybacks
Long-dated U.S. Treasury yields retreated sharply from near 19-year highs after the Treasury Department announced it would double the size of its liquidity support buyback operations. The repurchases will target the 10-year to 30-year sectors of the market, effectively easing recent borrowing cost anxieties.
search_spark
Dive deeper with AI
Moderna shares skyrocket on positive cancer vaccine trial results
Shares of Moderna nearly doubled in value following highly successful late-stage clinical trial results for its experimental mRNA-based melanoma vaccine, which was tested in combination with Merck's Keytruda. The announcement also lifted Merck's stock alongside other prominent biotech peers.
search_spark
Dive deeper with AI
Oil prices expand gains amid ongoing Middle East tensions
Crude oil futures extended their upward trajectory, touching multi-week highs as diplomatic stagnation continues regarding regional geopolitical friction. The ongoing disputes have specifically stoked investor concerns over potential shipping disruptions surrounding the critical Strait of Hormuz.
search_spark
Dive deeper with AI
Latest updates
Live
·3 min. ago
·3 min. ago
·5 min. ago
·5 min. ago
Show morekeyboard_arrow_down
Upcoming earnings
More upcoming earnings chevron_rightMore news stories
From web sources and news partners
Benzinga
·
3 minutes ago
Cameron Winklevoss Calls Bitcoin at $65,000 an 'Unprecedented' Buy: Does the Data Agree?
News Corp
·
3 minutes ago
Gold Up 2% Amid Weaker Dollar, Falling Bond Yields
News Corp
·
5 minutes ago
Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock is soaring.
Benzinga
·
5 minutes ago
Stock of the Day: Is Walmart Setting up to Rally Ahead of its Earnings?
AI content may include mistakes. Learn more